HUP0101046A3 - Amino anthracyclinone derivatives useful in the treatment of amyloidosis and medicines containing them - Google Patents

Amino anthracyclinone derivatives useful in the treatment of amyloidosis and medicines containing them

Info

Publication number
HUP0101046A3
HUP0101046A3 HU0101046A HUP0101046A HUP0101046A3 HU P0101046 A3 HUP0101046 A3 HU P0101046A3 HU 0101046 A HU0101046 A HU 0101046A HU P0101046 A HUP0101046 A HU P0101046A HU P0101046 A3 HUP0101046 A3 HU P0101046A3
Authority
HU
Hungary
Prior art keywords
amyloidosis
amino
treatment
derivatives useful
medicines containing
Prior art date
Application number
HU0101046A
Other languages
English (en)
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of HUP0101046A2 publication Critical patent/HUP0101046A2/hu
Publication of HUP0101046A3 publication Critical patent/HUP0101046A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU0101046A 1998-03-10 1999-02-25 Amino anthracyclinone derivatives useful in the treatment of amyloidosis and medicines containing them HUP0101046A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9805080.0A GB9805080D0 (en) 1998-03-10 1998-03-10 Amino anthracyclinone derivatives
PCT/EP1999/001300 WO1999046254A2 (en) 1998-03-10 1999-02-25 Amino anthracyclinone derivatives and their use in the treatment of amyloidosis

Publications (2)

Publication Number Publication Date
HUP0101046A2 HUP0101046A2 (hu) 2001-08-28
HUP0101046A3 true HUP0101046A3 (en) 2002-12-28

Family

ID=10828304

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101046A HUP0101046A3 (en) 1998-03-10 1999-02-25 Amino anthracyclinone derivatives useful in the treatment of amyloidosis and medicines containing them

Country Status (23)

Country Link
US (1) US6268362B1 (hu)
EP (1) EP1062206B1 (hu)
JP (1) JP2002506066A (hu)
KR (1) KR100603798B1 (hu)
CN (1) CN1113867C (hu)
AR (1) AR019831A1 (hu)
AT (1) ATE264302T1 (hu)
AU (1) AU755754B2 (hu)
BR (1) BR9908057A (hu)
CA (1) CA2321834A1 (hu)
DE (1) DE69916438D1 (hu)
EA (1) EA003333B1 (hu)
GB (1) GB9805080D0 (hu)
HU (1) HUP0101046A3 (hu)
ID (1) ID26084A (hu)
IL (1) IL137677A (hu)
NO (1) NO317260B1 (hu)
NZ (1) NZ506945A (hu)
PL (1) PL193245B1 (hu)
TW (1) TW528751B (hu)
UA (1) UA51838C2 (hu)
WO (1) WO1999046254A2 (hu)
ZA (1) ZA991839B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20110264A1 (it) * 2011-05-27 2012-11-28 Univ Degli Studi Milano Nuovi composti triciclici glicofusi, procedimento per la loro produzione e loro impiego quali ligandi dei peptidi ss amiloidi (ass).

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL110289A (en) 1993-08-06 1998-01-04 Policlinico San Matteo Istitut Pharmaceutical preparations containing 4-iodo-4-deoxydoxorubicin for the treatment of amyloidosis
GB9416007D0 (en) * 1994-08-08 1994-09-28 Erba Carlo Spa Anthracyclinone derivatives
GB9516349D0 (en) 1995-08-09 1995-10-11 Pharmacia Spa Aza-anthracyclinone derivatives
GB9613433D0 (en) * 1996-06-26 1996-08-28 Pharmacia Spa Fluoro labelled anthracyclinone and anthracycline derivatives

Also Published As

Publication number Publication date
IL137677A0 (en) 2001-10-31
EP1062206A2 (en) 2000-12-27
KR100603798B1 (ko) 2006-07-25
BR9908057A (pt) 2000-10-31
CA2321834A1 (en) 1999-09-16
WO1999046254A3 (en) 1999-10-21
DE69916438D1 (de) 2004-05-19
PL344086A1 (en) 2001-09-24
ID26084A (id) 2000-11-23
NO20004406L (no) 2000-10-30
US6268362B1 (en) 2001-07-31
IL137677A (en) 2005-08-31
ATE264302T1 (de) 2004-04-15
HUP0101046A2 (hu) 2001-08-28
AU2930899A (en) 1999-09-27
KR20010041737A (ko) 2001-05-25
JP2002506066A (ja) 2002-02-26
ZA991839B (en) 1999-12-22
CN1291977A (zh) 2001-04-18
AU755754B2 (en) 2002-12-19
NZ506945A (en) 2002-06-28
UA51838C2 (uk) 2002-12-16
NO20004406D0 (no) 2000-09-04
CN1113867C (zh) 2003-07-09
WO1999046254A2 (en) 1999-09-16
AR019831A1 (es) 2002-03-20
GB9805080D0 (en) 1998-05-06
EA003333B1 (ru) 2003-04-24
PL193245B1 (pl) 2007-01-31
TW528751B (en) 2003-04-21
EA200000922A1 (ru) 2001-04-23
NO317260B1 (no) 2004-09-27
EP1062206B1 (en) 2004-04-14

Similar Documents

Publication Publication Date Title
IL114578A0 (en) Amino purine-béta-D ribofuranuronamide derivatives their preparation pharmaceutical compositions containing them and their use
GB2286395B (en) Diketopiperazine derivatives and pharmaceutical uses thereof
HUP0001192A3 (en) The use of topiramate and its derivatives for the preparation of pharmaceutical compositions treating obesity
PL329411A1 (en) Novel derivatives of benzazepin, therapeutic agents containing such derivatives and their application in production of therapeutic agents
GB9721437D0 (en) Heteroaromatic compounds and their use in medicine
HUP0000474A3 (en) Arylethenesulfonamide derivatives and drug composition containing the same
IL131319A0 (en) 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same
IL114795A0 (en) N-benzylindole- and benmzopyrazole derivatives their preparation and use
IL133097A0 (en) Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof
GB2286393B (en) Piperazinedione derivatives and pharmaceutical uses thereof
IL116525A0 (en) Piperazinedione derivatives their preparation and use
IL125775A0 (en) Use of a zwitterion composition and a pharmaceutical composition containing the same
HUP0102109A3 (en) Sweetener composition and uses thereof
HUP0101733A3 (en) Pharmaceutical compositions containing sulfonyl-dipeptides and their use
IL142778A0 (en) Therapeutic product and its use
GB9413090D0 (en) Benzazepine derivatives compositions containing them and their use in therapy
IL128902A0 (en) N-(2-benzothiazolyl)-1-piperidineethanamine derivatives their preparation and their use in therapy
IL91451A0 (en) Pharmaceutical compositions comprising azapiron compounds and their use in the treatment of addiction
IL123156A0 (en) Benzenesulphonamide derivatives their preparation and their application in therapy
IL115982A0 (en) Cyclolignan derivatives and pharmaceutical compositions containing the same
ZA959904B (en) Iminooxymethyleneanilides thei preparation and their use
HUP0101046A3 (en) Amino anthracyclinone derivatives useful in the treatment of amyloidosis and medicines containing them
ZA9811344B (en) New azulene derivatives and medicaments containing same
IL114161A0 (en) Amido- quinoxalinediones pharmaceutical compositions containing them and their use
IL118629A0 (en) N-Substituted cis-N-propenyl-acetemides their preparation and use